EnteroMedics plans $86M IPO for obesity-control implants
EnteroMedics, a St. Paul, Minn., developer of obesity-treatment implants, filed to raise up to $86.25 million in an IPO. Its S-1 filing with the SEC is here.
The company is developing a neuromodulation implant called VBLOC that is designed to intermittently disrupt signals sent along the… Continue Reading